1. by Christine L. Kempton, and Amanda B. Payne
HLA-DRB1–factor VIII binding is a risk factor for inhibitor development in nonsevere hemophilia: a case-control study
by Christine L. Kempton, and Amanda B. Payne
BloodAdv
Volume 2(14):
July 24, 2018
©2018 by American Society of Hematology

2. Professional illustration by Patrick Lane, ScEYEnce Studios.
Christine L. Kempton, and Amanda B. Payne Blood Adv 2018;2:
©2018 by American Society of Hematology

3. Flow diagram of subject inclusion.
Christine L. Kempton, and Amanda B. Payne Blood Adv 2018;2:
©2018 by American Society of Hematology

4. Location and frequency of mutations on factor 8.
Christine L. Kempton, and Amanda B. Payne Blood Adv 2018;2:
©2018 by American Society of Hematology